SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma.
Ping ZhouWei YaoLijuan LiuQiujin YanXiaobei ChenXiaocui WeiShuang DingZhao LvFan ZhuPublished in: Cellular oncology (Dordrecht) (2024)
/JNK signaling pathway. This insight suggested that SPG21 could be recognized as a potential oncogene, offering a novel perspective on its role as a prognostic factor and a therapeutic target in the context of HCC.